asd1News and health tips, psychology and welfare Of 35 semen quality and sperm count had significantly decreased.

But, with what one docked good tree, good shade shelters him is not difficult to avoid the effects of high temperatures if we are healthy shelter of alcohol, tobacco or certain foods so tempting summer and fries or hamburger.

A habit that people take during their vacation very important for the quality of their reproductive cells. According to a study of fertility clinic during Jelly Gamat Gold G the summer Ginefiv should not neglect healthy behaviors we are trying to follow the rest of the year. The effectiveness of the male reproductive cells can be reduced if the necessary precautions are taken to high temperature and semen quality will be seriously affected.

So explain some recent studies claim that continued exposure can lead to heat different anomalies such as astenoszoospermia male, a sperm motility disorders, or oligospermia, which comes lower sperm count in the ejaculate. Therefore, in the holiday period, a specialist Ginefiv given the importance of not ignoring summer healthy habits, especially couples who want to have children. Among its recommendations, highlighting some.

Avoid increase in testicular temperature and continually expanded with the use of tight clothing habits or constant exposure to heat.

Eliminate alcohol and tobacco. Reproductive health of men and women displayed significantly altered in people who regularly smoke. In the former case, the tobacco can cause problems in the cement composition. Nicotine cigarettes have a variety of compounds that can cause breaks in the DNA of sperm. As for alcohol, several studies suggest that drinking can affect testosterone rough, male hormone involved in sperm production.

A balanced diet and healthy lifestyle are essential to enjoy good reproductive health. Summer is ideal to include the contribution of food salad cheese or yogurt and orange juice fortified with calcium. In addition, moderate physical exercise always avoid midday, and wear light, loose clothing habits that prevent some of the negative effects of heat on male fertility.

Every year malaria half a million people. And half of the world’s population was in the area at risk of infection. Therefore, a vaccine against malaria is welcome and desirable development.
These days the European Medicines Agency, EMA has given the green light for a new vaccine against the disease, ensuring that effective use in infants at risk of contracting it. Only remains to know if the World Health Organization, WHO, which was adopted at the end of the year. And the debate seems to be very difficult.
RTS, S vaccine, also called Mosquirix, was developed by the pharmaceutical company GlaxoSmithKline UK and partly funded by the Bill and Melinda Gates Foundation. Mosquirix not the only vaccine available, at the top, US PfSPZ Sanaria created the same or even more effective in preventing malaria infection. But Mosquirix is ​​the first to get this far along the approval process.

RTS, S helps prevent infection by Plasmodium falciparum,

one of the most deadly malaria parasite. The vaccine induces the body to produce more antibodies to prevent the parasite infects the liver. Specifically designed to fight infections in children, excluding used by adults.
The problem is that the first results of a clinical trial showed that three doses of the vaccine can reduce the risk of infection by half in children aged 5 and 17 months. In young infants between 6 and 12 weeks, the infection was reduced only 30%. And if that was not enough, over time, reduce the effectiveness of Mosquirix except children received a booster dose. However, the possibility of a contract malaria or die, has not changed at all.

No wonder that some scientists worry that the potential costs associated with such a complex vaccine and why deny it,

rather ineffective may outweigh the benefits. However, Africa needs a malaria vaccine, even if only partially effective. “This vaccine could mean that many children will have only two episodes of malaria per year, instead of five,” said Dr. Martin De Smet, malaria expert at Doctors Without Borders, in a recent interview. WHO must decide whether sufficient justification to recommend a public Mosquirix